National Center for Complementary and Integrative Health | National Heart, Lung, and Blood Institute |
---|---|
FDA drug safety communication: Important safety label changes to cholesterol-lowering statins drugs |
Hyperlipidemia: Lifestyle measures for prevention of coronary artery disease adult.
Hyperlipidemia: Screening for coronary artery disease adult | Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents |
---|---|
American Association for Clinical Chemistry | : Mayo Foundation for Medical Education and Research; 2018 |